Phase I/II dose escalation study of recombinant human interleukin‐11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study*Mitchell S. Cairo, Gregory H. Reaman, Stacy L. Berg et al.|British Journal of Haematology|2004Cited by 32
A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities.Francisco Bracho, Mitchell S. Cairo, Mark Krailo et al.|PubMed|2001Cited by 17